Clinical Trial Update: A Phase 2 Open-label Study to Evaluate the Safety of Laruparetigene Zovaparvovec Administered Bilaterally in Male Participants With X-Linked Retinitis Pigmentosa [Phase 2]

View source ↗

Summary

This is a Phase 2 open-label study to evaluate the safety of Laruparetigene Zovaparvovec administered bilaterally in male participants with X-linked retinitis p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• X-linked Retinitis Pigmentosa

Drugs mentioned

• Laruparetigene Zovaparvovec

Snippet

Sponsor: Beacon Therapeutics | Conditions: X-Linked Retinitis Pigmentosa (XLRP) | Phase 2 | Status: RECRUITING